Manulife (Manufacturers Life Insurance)
STLN

Manulife (Manufacturers Life Insurance)’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.2K Buy
21,894
+63
+0.3% +$193 ﹤0.01% 2696
2025
Q4 		$77.7K Buy
21,831
+1,037
+5% +$3.85K ﹤0.01% 2757
2025
Q3 		$72.6K Sell
20,794
-97
-0.5% -$332 ﹤0.01% 2837
2025
Q2 		$42.8K Buy
+20,891
New +$52.2K ﹤0.01% 2899

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s STLN Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 0.29% in Q1 2026, buying an estimated $193 and bringing the position to 21,894 shares worth $67.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2696.

Manulife (Manufacturers Life Insurance) first reported a position in STLN in Q2 2025 and has held it in 4 quarters since. The position peaked at $77.7K in Q4 2025. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 21,894 shares of Starling Oncology Institute, Inc. Common Stock worth $67.2K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 63 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $193.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2696 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2025 and has held it in 4 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Starling Oncology Institute, Inc. Common Stock position peaked at $77.7K in Q4 2025.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.